by Brian Shilhavy
Editor, Health Impact News

The experimental Johnson and Johnson COVID shot has been halted by the FDA and CDC here in the United States, reportedly because “rare” blood clots were seen in six women following injections, resulting in one death.

However, reports coming in now show the problem is probably much more widespread than what the FDA and CDC are reporting.

As we reported yesterday, WLOX out of St. Martin, Mississippi, reported on a “young and healthy” father of 7 in Mississippi who suffered a stroke and is paralyzed and in the hospital in critical condition following an injection of the Johnson and Johnson experimental COVID shot.

Today, The COVID Blog is reporting the death of a young 21-year-old University of Cincinnati pre-med student who has died within 24 hours of receiving the Johnson and Johnson COVID injection.

Mr. John Francis Foley was a National Honor Society pre-med student at the University of Cincinnati. He made the Dean’s List every semester and volunteered for several organizations in his free time.

Mr. John Francis Foley voluntarily received the experimental Johnson & Johnson viral vector shot on Saturday morning, April 10 – two days before the CDC/FDA pause. He felt ill that evening, according to accounts on Facebook.

The 21-year-old college junior went to sleep, hoping he’d feel better after a good night’s rest.

But he never woke up.

Young Mr. Foley died peacefully in his sleep that night, according to his mother, Mary Beth Foley.

Jennifer Snyder Benedict, mother of John’s friend Maddie Benedict, also announced his death and J&J shot on Facebook. Mr. Foley’s death was also confirmed by his aunt.

Crisis communications attorney Mark R. Weaver released a statement on behalf of the family.

Read the full article at The COVID Blog.

FDA Pause on J&J COVID Shots Continues

FiercePharma is reporting today that the FDA will continue the halt on the J&J COVID shots as they gather more data.

U.S. vaccine experts have identified three potential options for Johnson & Johnson’s COVID-19 vaccine in the U.S. going forward. But while they wait for more data, the shot’s nationwide pause will continue.

Moving forward, the United States could continue the vaccine’s use with a safety warning, or it could put age and gender restrictions on the product. Officials could also discontinue use of the shot entirely, experts at the CDC’s Advisory Committee on Immunization Practices said during a Wednesday meeting.

For now, though, the group has decided to punt on any decisions and collect more data. The group plans to meet in about a week for a new session.

This signals that the shot’s pause will extend longer than indicated by the FDA on Tuesday, when acting commissioner Janet Woodcock said she expected it to last a “matter of days.”

With Pfizer and Moderna supplying a combined 14 million vaccine doses weekly to the U.S., there is less urgency to solve the safety issue of J&J shot, Sara Oliver of the CDC said on Wednesday.

The Wednesday meeting came after U.S. officials on Tuesday recommended a pause to the shot’s rollout after rare but serious blood clots in six people after vaccination. One died and one was in critical condition, officials said Tuesday. About 7 million people had been vaccinated before the pause.

Of the six CVST cases in the U.S., all have been white women between the ages of 18 and 48. The clots have occurred between 6 and 13 days after vaccinations. More cases could surface because around half of the J&J doses administered were in the last two weeks, officials said. (Source.)

It will be interesting to see if 43-year-old Brad Malagarie from Mississippi who is now paralyzed from the J&J shot, and 21-year-old John Francis Foley who is now dead following the J&J shot, will be included in their analysis.

The FDA is looking at a very rare condition where blood clots happen in combination with low blood platelets.

But what if blood clots happen without “low blood platelets”? Will those deaths and injuries then just be explained away as “coincidence”?

What about all the other reported deaths following the experimental COVID injections that are much more prevalent than deaths by fatal blood clots?

As we have previously reported, there are far more deaths following the Pfizer and Moderna mRNA shots than the J&J shots, and yet for some reason only the J&J shots are being paused.

What are the determining factors for the FDA and CDC to make a decision to halt experimental COVID shots where now over 3000 deaths have been recorded following the experimental COVID injections, more deaths than what have been recorded following vaccines for that past 13+ years? See:

21-Year-Old University of Cincinnati Student DEAD 24 Hours after Johnson & Johnson COVID Injection

FDA Pause on J&J COVID Shots Continues

Over 12 MILLION Views!

COVID-19 “Vaccine” Casualties List

Understand the Times We are Currently Living Through

We Are Now on Telegram. Video channels at Bitchute, and Odysee.

Share This Story, Choose Your Platform!

3 Comments

Join the DiscussionCancel reply

Top Stories This Week